Neuropsychopharmacology
- GM-1020: a novel, orally bioavailable NMDA receptor antagonist with rapid and robust antidepressant-like effects at well-tolerated doses in rodents3 years ago
- Acetylcholine muscarinic M1 receptors in the rodent prefrontal cortex modulate cognitive abilities to establish social hierarchy3 years ago
- Social odor choice buffers drug craving3 years ago
- Combined treatment with naloxone and the alpha2 adrenoceptor antagonist atipamezole reversed brain hypoxia induced by a fentanyl-xylazine mixture in a rat model3 years ago
- TAAR1 agonist ulotaront modulates striatal and hippocampal glutamate function in a state-dependent manner3 years ago
- Methylphenidate with or without fluoxetine triggers reinstatement of cocaine seeking behavior in rats3 years ago
- A systematic review and meta-analysis of neuromodulation therapies for substance use disorders3 years ago
Journal of Psychopharmacology
- Nitric oxide-mediated defensive and antinociceptive responses organised at the anterior hypothalamus of mice are modulated by glutamatergic inputs from area 24b of the cingulate cortex6 years ago
- Effects of repeated adolescent exposure to cannabis smoke on cognitive outcomes in adulthood6 years ago
- MicroRNA-195 predicts olanzapine response in drug-free patients with schizophrenia: A prospective cohort study6 years ago
- Presynaptic vesicular accumulation is required for antipsychotic efficacy in psychotic-like rats6 years ago
- Sex-specific sensitivity to methamphetamine-induced schizophrenia-relevant behaviours in neuregulin 1 type III overexpressing mice6 years ago
- Oxytocin-induced facilitation of learning in a probabilistic task is associated with reduced feedback- and error-related negativity potentials6 years ago
- Effects of lorazepam on prosaccades and saccadic adaptation6 years ago
European Neuropsychopharmacology
- Comorbidities and behavioral issues5 years ago
- Sex-specific associations of basal steroid hormones and neuropeptides with Conduct Disorder and neuroendocrine mediation of environmental risk5 years ago
- Commentary on: Comparative effects of (S)-ketamine and racemic (R/S)-ketamine on psychopathology, state of consciousness, and neurocognitive performance in healthy volunteers5 years ago
- Cognitive impairments four months after COVID-19 hospital discharge: pattern, severity and association with illness variables5 years ago
- Dorsal and ventral striatal neuronal subpopulations differentially disrupt male mouse copulatory behavior5 years ago
- A white paper on a neurodevelopmental framework for drug discovery in autism and other neurodevelopmental disorders5 years ago
- Regulatory considerations in drug development for autism spectrum disorders5 years ago